A real world study assessing efficacy of 12 weeks sofosbuvir, daclastivir with ribavirin in cirrhotic pre and post-transplant genotype 3 hepatitis C infected patients
Latest Information Update: 08 Jul 2017
At a glance
- Drugs Daclatasvir (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 08 Jul 2017 New trial record